Neurologic complications in adult living donor liver transplant patients: an underestimated factor?

F.H. Saner*, J. Gensicke, S.W. Olde Damink, G. Pavlakovic, J. Treckmann, M. Dammann, G.M. Kaiser, G.C. Sotiropoulos, A. Radtke, S. Koeppen, S. Beckebaum, V. Cicinnati, S. Nadalin, M. Malago, A. Paul, C.E. Broelsch

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Liver transplantation is the only curative treatment in patients with end-stage liver disease. Neurological complications (NC) are increasingly reported to occur in patients after cadaveric liver transplantation. This retrospective cohort study aims to evaluate the incidence and causes of NC in living donor liver transplant (LDLT) patients in our transplant center. Between August 1998 and December 2005, 121 adult LDLT patients were recruited into our study. 17% of patients experienced NC, and it occurred significantly more frequently in patients with alcoholic cirrhosis (42%) and autoimmune hepatitis (43%) as compared with patients with hepatitis B or C (9/10%, P = 0.013). The most common NC was encephalopathy (47.6%) followed by seizures (9.5%). The choice of immunosuppression by calcineurin inhibitor (Tacrolimus or Cyclosporin A) showed no significant difference in the incidence of NC (19 vs. 17%). The occurrence of NC did not influence the clinical outcome, since mortality rate, median ICU stay and length of hospital stay were similar between the two groups. Most patients who survived showed a nearly complete recovery of their NC. NCs occur in approximately 1 in 6 patients after LDLT and seem to be predominantly transient in nature, without major impact on clinical outcome.
Original languageEnglish
Pages (from-to)253-258
JournalJournal of Neurology
Issue number2
Publication statusPublished - 1 Jan 2010

Cite this